Read More

3/31/ · Are Ariad's Options Dwindling? Investor confidence in the company has been surprisingly steadfast, and the stock value has more than doubled over the . Shares of ARIAD Pharmaceuticals (NASDAQ: ARIA) are lower on the session by %, currently trading at $ The stock has been moving largely lower over the past three months. 1/9/ · Ariad's stock was on a roll in , rising percent. For , the stock has already surged around 90 percent, after accounting for Monday's gains. ARIA 1-year chart.

Read More

Exploring (NASDAQ:ARIA) stock? View ARIA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Options Trading from Scratch. ARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. Shares of ARIAD Pharmaceuticals (NASDAQ: ARIA) are lower on the session by %, currently trading at $ The stock has been moving largely lower over the past three months. 3/31/ · Are Ariad's Options Dwindling? Investor confidence in the company has been surprisingly steadfast, and the stock value has more than doubled over the .

Read More

Exploring (NASDAQ:ARIA) stock? View ARIA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Options Trading from Scratch. ARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. 3/31/ · Are Ariad's Options Dwindling? Investor confidence in the company has been surprisingly steadfast, and the stock value has more than doubled over the . 1/9/ · Ariad's stock was on a roll in , rising percent. For , the stock has already surged around 90 percent, after accounting for Monday's gains. ARIA 1-year chart.

Read More

Market Overview

Shares of ARIAD Pharmaceuticals (NASDAQ: ARIA) are lower on the session by %, currently trading at $ The stock has been moving largely lower over the past three months. Exploring (NASDAQ:ARIA) stock? View ARIA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Options Trading from Scratch. ARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. Ariad’s stock closed up % at $, with options heavily skewed towards the bullish side. Just after the opening bell, one option trader came in and sold 5, contracts of the May 11 strike put options for an average price of $ Remember, put sellers want the stock to remain above the strike price.

Are Ariad's Options Dwindling? | The Motley Fool
Read More

Motley Fool Returns

Exploring (NASDAQ:ARIA) stock? View ARIA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Options Trading from Scratch. ARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. 8/29/ · Remember, call option buyers want the stock to remain above the strike price. In this case, as long as Ariad trades above $ per share by September expiration, this trader will be very happy. After all, he has unlimited profit potential on his call options as long as the stock stays above this price. 3/31/ · Are Ariad's Options Dwindling? Investor confidence in the company has been surprisingly steadfast, and the stock value has more than doubled over the .